Regional Breakdowns of the Single-Photon Emission Computed Tomography Market Growth 2034

0
1KB

Single-Photon Emission Computed Tomography Market Research Report – Forecast till 2034

https://www.marketresearchfuture.com/reports/single-photon-emission-computed-tomography-market-7231

 

Single-Photon Emission Computed Tomography Market Highlights

Single-Photon Emission Computed Tomography Market Share is expected to reach at 6.90% CAGR during the forecast period 2025-2034

The growing acceptance of Single-Photon Emission Computed Tomography (SPECT) accustomed by its technical advances is one of the major trends witnessed in the global SPECT market over the forecast period. Imaging devices are becoming more advanced, efficient, and evolved in terms of technology. The SPECT scanner has two integral parts namely computed tomography (CT) and a radioactive material (tracer). Basically, these tracers are used to diagnose and predict outcomes in various disease states by monitoring the therapeutic effects.

The Single-Photon Emission Computed Tomography market insights is expected to witness tremendous growth owing to the new 99mtc labelled agents for visualizing biologically significant events, and integration of X-ray tomography (CT) In SPECT. Other key factors such significant investments in R&D and expansions undertaken by key players are contributing towards the growth of the market. However, challenges such as need for skilled professionals, and reimbursement issues, is likely to curb the market growth during the forecast period.

Single-Photon Emission Computed Tomography Market Key players

The global market is manifested with the presence of limited companies, leading to the consolidated nature of the market. The industry rivalry are expected to remain high throughout the forecast period. Several small and larger companies are involved in development of Single-Photon Emission Computed Tomography (SPECT) for diagnostic applications.

The Single-Photon Emission Computed Tomography Market Players are GE Healthcare, Siemens Healthcare, Koninklijke Philips N.V., Bruker Corporation, Mediso Ltd., Digirad Corporation, Spectrum Dynamics Medical, DDD-Diagnostic A/S, MiE America, Inc., CardiArc, Beijing Hamamatsu Photon Techniques INC., SHENZHEN BASDA MEDICAL APPARATUS CO., LTD. PNPMedM, NuCare Inc., and others.

Single-Photon Emission Computed Tomography Market Segmentation

The global Single-Photon Emission Computed Tomography market outlook is segmented into type, application, end-users. The Single-Photon Emission Computed Tomography (SPECT) market, by type, the market is segmented into hybrid SPECT systems, and standalone SPECT systems. On the basis of application, the Single-Photon Emission Computed Tomography (SPECT) market is bifurcated into oncology, cardiology, neurology, and others. On the basis of end-user, the market is segmented into hospitals, diagnostic imaging centers, academic & research centers, and others.

Single-Photon Emission Computed Tomography Market Regional Analysis

The Americas is the largest in the market owing to the improving research infrastructure in the region, coupled with the rising awareness among patients and physicians for radioisotopes. Further, SPECT has reportedly been combined with CT and MRI to provide detailed anatomical and metabolic information. It is currently exhibiting a highly lucrative growth rate due to an increased use of SPECT for diagnosis of cardiac diseases, brain diseases, etc.

The European region is the second largest SPECT market over the forecast period due to high acceptance of SPECT in research & development along with the rising incidence of chronic disease like cancers are also accountable for the growth of the Single-Photon Emission Computed Tomography (SPECT) market.

The Asia Pacific region is likely to develop at the uppermost CAGR for the Single-Photon Emission Computed Tomography (SPECT) market in the years to come. Moreover, the rising diagnostic care services both at the hospitals and at community level are expected to influence the market in a positive way. The Middle East and Africa accounts for the least market share due to low per capita income and lack of availability of well-trained healthcare professionals.

Related Reports-

 

Monoclonal Antibody Therapy Market

Sepsis Diagnostics Market

Coronary Artery Bypass Graft Market

Microscopy Devices Market

Urinary Incontinence Market

Patient Monitoring Devices Market

Capsule Market

Middle East-Africa Human Vaccines Market

For more information visit at MarketResearchFuture

Suche
Kategorien
Mehr lesen
News
Making F-35 & Eurofighter “Invisible”, UK Rolls Out ‘StormShroud’ Drones That Could Blind Enemy Radars
The British Royal Air Force (RAF) has unveiled its first-ever Autonomous Collaborative Platform...
Von Ikeji 2025-05-05 16:33:54 0 699
News
펩타이드 치료제 시장 통찰력: 파이프라인 개발 및 전략적 협력
세계 펩타이드 치료제 시장 규모는 2023년 425억 2천만 달러로 평가되었으며, 2024년 456억 1천만 달러에서 2031년 838억 3천만 달러로...
Von kpravin 2025-04-24 09:12:14 0 497
Andere
Comprehensive Building Surveys by CITY FIRE PROOFING LTD
Looking for reliable building surveys to ensure your property's safety and structural...
Von cityfireproofingltd 2025-03-12 07:29:51 0 839
Health
Almond Fragrance Oil
Almond fragrance oil, Almond fragrance oil supplier,best price in india -theyoungchemist We...
Von chemistyoung 2024-04-08 12:54:30 0 3KB
Startseite
Elan New Project: Exclusive 4 & 5 BHK Residences on 5.15 Acres in Sector 106, Gurgaon
Elan New Project in Sector 106, Gurgaon, represents the epitome of luxury living. Spread across...
Von jyotisinghal 2024-12-21 06:13:45 0 1KB